- Contract Development of Biosimilars
CLONOVA offers end-to-end biosimilar development services, including cell line development, upstream and downstream process optimization, and assay development. Our integrated approach ensures high-yield, scalable, and regulatory-compliant biosimilar programs tailored to meet client specifications and accelerate time-to-market.
2. Clinical Manufacturing of Biologics
We provide clinical-scale biologics manufacturing using single-use bioreactors up to 100 L. Our flexible and cGMP-compliant facilities support the production of monoclonal antibodies, recombinant proteins, and other biologics for preclinical and early-phase clinical studies, ensuring quality and consistency at every stage.
3. Aseptic Fill-Finish Services
CLONOVA delivers aseptic fill-finish solutions for biologics, peptides, and other injectable formulations, supporting both liquid and lyophilized vial presentations. Designed for R&D and clinical use, our facilities maintain stringent environmental controls and aseptic processing standards to ensure product sterility, stability, and integrity.
